BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 22, 2010
View Archived Issues
Banyu and Merck & Co. claim novel Akt1 inhibitors for cancer therapy
Read More
Everolimus effective in patients with metastatic pancreatic neuroendocrine tumors
Read More
Synta Pharmaceuticals discloses Hsp90 inhibitors for the treatment of cancer
Read More
TRPA1 antagonists described by Janssen for the treatment of pain
Read More
Roche describes liver X receptor agonists for the treatment of atherosclerosis
Read More
Novartis claims ENaC blockers for the treatment of cystic fibrosis
Read More
Oramed completes patient enrollment in pivotal phase IIb trial of ORMD-0801
Read More
Orexin receptor antagonists for treating sleep disorders claimed by Actelion
Read More
Cobalamin oral insulin shows promise in preclinical trials
Read More
Michael J. Fox Foundation awards grant for neuroprotective therapies for PD
Read More
Halozyme Therapeutics enters research alliance with BioAtla
Read More
Novel hybrid potentiator-corrector molecule for the treatment of CF disclosed
Read More
Generation of tumor-targeted nanoparticles for potential clinical use
Read More
Sorafenib shows low activity in phase II trial in advanced biliary tract carcinoma
Read More
Dal-OUTCOMES trial to evaluate dalcetrapib in acute coronary syndrome
Read More
NS3/4A protease inhibitors reported by BMS for HCV infection
Read More
Shionogi's Cymbalta approved for depression in Japan
Read More
Schering-Plough obtains Japanese approval for Bridion
Read More
Wyeth launches BeneFIX for hemophilia B
Read More
ImmunoCellular's ICT-107 vaccine specifically targets cancer stem cells
Read More
Bharat Biotech initiates phase I clinical trial of HN-VAC H1N1 vaccine
Read More
Lexicon's LX-4211 demonstrates improvements in phase II trial in type 2 diabetes
Read More
New dosage form of Mitsubishi Tanabe's neuroprotectant Radicut approved
Read More
BTG initiates phase IIa study of Pleneva in multiple sclerosis
Read More
4SC commences dosing in a first-in-man phase I study of 4SC-203
Read More
Mitsubishi Tanabe's Remicade approved for the additional indication of psoriasis
Read More